Lymphatic malformations

Lymphatic Research and Biology

Volumn 2, Issue 1, 2004, Pages 25-31

  Smith, Richard J H ^a  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; PICIBANIL; SCLEROSING AGENT;

AIRWAY CONSTRICTION; ARTICLE; BIRTH; BLEEDING; CONGENITAL BLOOD VESSEL MALFORMATION; DIATHERMY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EDEMA; EMBRYOLOGY; FLU LIKE SYNDROME; HEAD AND NECK MALFORMATION; HUMAN; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LYMPH VESSEL; NEURITIS; PAIN; PATHOGENESIS; PRIORITY JOURNAL; RADIOTHERAPY; RECURRENCE RISK; SURGICAL TECHNIQUE;

HUMANS; LYMPHATIC VESSELS; PICIBANIL; SCLEROTHERAPY;

EID: 4444365471     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/1539685041690436     Document Type: Article

References (28)

1. Giguère CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pransky S, Kelley P, Georgeson K, Smith RJH. Treatment of lymphangiomas with Picibanil (OK-432) sclerotherapy - A prospective multi-institutional trial. Arch Otolaryngol 2002;128: 1137-1144.
2. Anderson DH. Tumors of infancy and childhood. Cancer 1951;4:890-895.
3. Bill AH Jr, Summer DS. A unified concept of lymphagioma and cystic hygroma. Surg Gynecol Obstet 1965;120:79-86.
4. Musone R, Bonafiglia R, Menditto A, Paccone M, Cassese E, Russo G, Balbi C. Fetuses with cystic hygroma. A retrospective study. Panminerva Med 2000;42:39-43.
5. Ranvier LA. Comptes Rendus 1895;121:1009.
6. Sabin FR. On the origin of the lymphatic system from the veins and the development of the lymph heart and thoracic duct in the pig. Am J Anat 1901; 1:367-389.
7. Huntington GS, McClure CFW. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Anat Rec 1908;2:1-19.
8. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. PNAS 2001;98: 12677-12682.
9. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-1513.
10. Broomhead IW. Cystic hygroma of the neck. Br J Plast Surg 1964;17:225-244.
11. Grabb WC, Dingman RO, Oneal RM, Dempsey PD. Facial hamartomas in children: Neurofibroma, lymphangioma, and hemangioma. Plast Reconstr Surg 1980;66:509-527.
12. Nihn TN, Nihn TX. Cystic hygroma in children: A report of 126 cases. J Pediatr Surg 1974;9:191-195.
13. Gross RE, Goeringer CF. Cystic hygroma of the neck. Surg Gynecol Obstet 1939;69:48-60.
14. Galofre M, Judd ES, Perez PE, Harrison EG Jr. Results of surgical treatment of cystic hygroma. Surg Gynecol Obstet 1962;127:319-326.
15. Stromberg BV, Weeks PM, Wray RC. Treatment of cystic hygroma. South Med J 1976;69:1333-1335.
16. Giguère CM, Bauman NM, Smith RJH. New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 2002; 111:1066-1075.
17. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995;20:1282-1287.
18. Chirigos MA. The immunomodulatory activity of Picibanil (OK-432). In: Hoshino T, Uchida A. eds. Clinical and Experimental Studies in Immunotherapy. Amsterdam: Excerpta Medica; 1983:20-31.
19. Ishida N, Hoshino T. A streptococcal prepartion as a potent biological response modifier OK-432. 2nd Ed. Amsterdam: Excerpta Medica. 1985: 1-70.
20. Rautio R, Keski-Nisula L, Laranne J, Laranne J, Laaasonen E. Treatment of lymphangiomas with OK-432 (Picibinal). Cardiovasc Intervent Radiol 2003;26: 31-6.
21. Giguère CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pransky S, Kelley P, Georgeson K, Smith RJ. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: A prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 2002;128:1137-1144.
22. Claesson G, Kuylenstierna R. OK-432 therapy for lymphatic malformation in 32 patients (28 children). Int J Pediatr Otorhinolgaryngol 2002;65:1-6.
23. Laranne J, Keski-Nisula L, Rautio R, Rautianinen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol 2002;259:274-278.
24. Brewis C, Pracy JP, Albert DM. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil). Clin Otolaryngol 2000;25:130-134.
25. Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2000;82:316-318.
26. Motiwale SS, Karmarkar SJ, Oak SN, Kurkarni BK, Deshmukh SS. OK-432 injection therapy for lymphangiomas. Indian Pediatr 1996;33:686-688.
27. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994;29:784-785.
28. Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima M, Iwai N. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 1991;26:263-268.